<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>FDC Use Cases</title>
  <link rel="stylesheet" href="fdc_styles.css" />
</head>
<body>

  <div class="header">
    <h1>FDC Use Cases</h1>
    <nav>
      <a href="fdc_index.html">Back to Index</a> |
      <a href="fdc_overview.html">Overview</a> |
      <a href="fdc_tiers.html">Tier Access</a>
    </nav>
  </div>

  <div class="main-content">

    <h2>1. Therapeutic Targeting</h2>
    <p>FDCs are capable of binding selectively to disease-specific targets using non-traditional binding modes (e.g., metal-coordination, ionic threading, supramolecular docking).</p>

    <h2>2. Molecular Imaging & Diagnostics</h2>
    <p>FDC structures can be embedded with imaging markers (e.g., fluorescent, radioactive, magnetic) for diagnostics or real-time tracking.</p>

    <h2>3. Resistance Management</h2>
    <p>Multifunctional complexes disrupt common mutation-driven resistance patterns by interacting with targets at multiple functional levels simultaneously.</p>

    <h2>4. Hybrid Material Integration</h2>
    <p>Use in implant coatings, bioelectronic interfaces, or responsive drug release systems with controlled behavior under varying pH, redox, or metal gradients.</p>

    <h2>5. Ethical Access Deployment</h2>
    <p>Tier-based licensing allows critical FDC compounds to be deployed in low-income regions with non-profit access models while supporting commercial IP protection in developed markets.</p>

  </div>

  <div class="footer">
    &copy; 2025 Kunfirm Technologies | FDC Public Tier 0
  </div>

</body>
</html>
